Daniela Annibali

1. MAROLT, Nika, ZOTTEL, Alja, AMANT, Frederic, ANNIBALI, Daniela, LANIŠNIK-RIŽNER, Tea. Medroxyprogesterone acetate and mefenamic acid as potentional strategies to overcome platinum resistance in high-grade serous ovarian carcinoma. V: HITNER, Ivana (ur.), GABRIČ, Maša (ur.). Connecting ideas, oncology innovations at the bench : next generation sequencing, Ilumina Miseq i100 Innovations, microscopy, Nikon Eclipse UI, pathology, oncology research, hematologic diseases, ovarian cancer : [the Kemomind Science Conference]. Ljubljana: Kemomed, 2025. Str. 21. The Kemomind Science Conference, 2025, 01. ISBN 978-961-91450-7-4. ISSN 2670-5133. [COBISS.SI-ID 269197059]
projekt: J3-60065, P3-0449; financer: ARIS

2. MAROLT, Nika, AMANT, Frederic, ANNIBALI, Daniela, LANIŠNIK-RIŽNER, Tea. Repurposing medroxyprogesterone acetate and mefenamic acid for platinum-resistant ovarian cancer. V: KRANJC BREZAR, Simona (ur.), ČEMAŽAR, Maja (ur.), MARINKO, Tanja (ur.). 2. slovenski znanstveni simpozij o raziskavah raka : Tekočinska biopsija v onkologiji : zbornik prispevkov in povzetkov : 10. oktober 2025, Onkološki inštitut Ljubljana. 1. izd. Ljubljana: Onkološki inštitut: Združenje za radioterapijo in onkologijo pri Slovenskem zdravniškem društvu, 2025. Str. 86. ISBN 978-961-7248-09-8. DiRROS - Digitalni repozitorij raziskovalnih organizacij Slovenije. [COBISS.SI-ID 255360003]
projekt: J3-60065, P3-0449; financer: ARIS

3. MAROLT, Nika, AMANT, Frederic, ANNIBALI, Daniela, LANIŠNIK-RIŽNER, Tea. Repurposing MPA and mefenamic acid for HGSOC : inhibition of AKR1C as a therapeutic strategy. V: GJORGOSKA, Marija (ur.), et al. 2. Scientific Meeting Translational Molecular Endocrinology : 17th September 2025, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia : book of abstracts. Digital ed., PDF format. Ljubljana: Založba UL MF, 2025. Str. 22. ISBN 978-961-94794-9-0. https://www.mf.uni-lj.si/application/files/3417/5828/6314/Book_of_abstracts_2TME_2025_cip_v2.pdf. [COBISS.SI-ID 255353603]
projekt: J3-60065, P3-0449; financer: ARIS

4. MAROLT, Nika, AMANT, Frederic, ANNIBALI, Daniela, ZOTTEL, Alja, LANIŠNIK-RIŽNER, Tea. Targeting AKR1C enyzmes in high-grade serous ovarian cancer : antitumor effects of MPA and mefenamic acid. V: NADIŽAR, Nejc (ur.). 20th CFGBC Symposium : book of abstracts : Slovenia, 11th – 12th June 2025. Electronic version. Ljubljana: University of Ljubljana, Faculty of Medicine, 2025. Str. 64. http://cfgbc.mf.uni-lj.si/wp-content/uploads/2025cfgbcsym20_bookofabstracts.pdf. [COBISS.SI-ID 240770563]

5. MAROLT, Nika, ZOTTEL, Alja, ANNIBALI, Daniela, AMANT, Frederic, LANIŠNIK-RIŽNER, Tea (avtor, korespondenčni avtor). AKR1C inhibitors medroxyprogesterone acetate and mefenamic acid exhibit antitumor activity alone and combined with carboplatin in platinum-resistant high-grade serous ovarian cancer models. Biomedicine & pharmacotherapy. 2026, vol. 196, [article no.] 119079, str. 1-18, ilustr. ISSN 1950-6007. https://www.sciencedirect.com/science/article/pii/S0753332226001113?via%3Dihub, Repozitorij Univerze v Ljubljani – RUL, DOI: 10.1016/j.biopha.2026.119079. [COBISS.SI-ID 269987075]
projekt: P3-067; financer: Slovenian Research and Innovation Agency
projekt: 20240125; financer: Unicersity Medical Centre